PubRank

T Le Chevalier

Author PubWeight™ 98.90‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst 1995 3.25
2 Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data. Lancet 2010 3.21
3 Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. J Clin Oncol 2000 2.48
4 Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients. Ann Oncol 2006 2.18
5 ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. GETCB (Groupe d'Etude et Traitement des Cancers Bronchiques), FNCLCC (Féderation Nationale des Centres de Lutte contre le Cancer) and the CEBI trialists. Int J Radiat Oncol Biol Phys 1991 1.91
6 Etoposide plus cisplatin with or without the combination of 4'-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: a French Federation of Cancer Institutes multicenter phase III randomized study. J Natl Cancer Inst 2001 1.82
7 Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome. Ann Oncol 2004 1.81
8 Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer. N Engl J Med 1993 1.69
9 A retrospective analysis of the outcome of patients who have received two prior chemotherapy regimens including platinum and docetaxel for recurrent non-small-cell lung cancer. Lung Cancer 2003 1.63
10 Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol 1989 1.60
11 Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy? Ann Oncol 2010 1.58
12 Carcinoma of an unknown primary site: a chemotherapy strategy based on histological differentiation--results of a prospective study. Ann Oncol 2001 1.44
13 Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products. J Clin Invest 1997 1.39
14 Sites of primary malignancies in patients presenting with cerebral metastases. A review of 120 cases. Cancer 1985 1.37
15 High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas. J Clin Oncol 1995 1.36
16 Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study. Eur J Cancer 1996 1.32
17 Economic evaluation of a randomized clinical trial comparing vinorelbine, vinorelbine plus cisplatin, and vindesine plus cisplatin for non-small-cell lung cancer. J Clin Oncol 1995 1.31
18 Do all patients with advanced non-small-cell lung cancer benefit from cisplatin-based combination therapy? Ann Oncol 2001 1.28
19 Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung carcinoma. J Natl Cancer Inst 1992 1.22
20 Surgery for lung metastases from colorectal cancer: analysis of prognostic factors. J Clin Oncol 1996 1.21
21 Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel. Ann Oncol 2004 1.17
22 Patterns of relapse of N2 nonsmall-cell lung carcinoma patients treated with preoperative chemotherapy: should prophylactic cranial irradiation be reconsidered? Cancer 2001 1.10
23 Docetaxel and interstitial pulmonary injury. Ann Oncol 1997 1.09
24 Immunohistochemichal expression of biomarkers: a comparative study between diagnostic bronchial biopsies and surgical specimens of non-small-cell lung cancer. Ann Oncol 2007 1.07
25 Phase I study of a recombinant adenovirus-mediated gene transfer in lung cancer patients. J Natl Cancer Inst 1996 1.06
26 Primary chemotherapy in the treatment of inflammatory breast carcinoma: a study of 230 cases from the Institut Gustave-Roussy. J Clin Oncol 1986 1.05
27 Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer: analysis of 505 randomized patients. Ann Oncol 2002 1.05
28 Primary mediastinal nonseminomatous germ cell tumors: results of modern therapy including cisplatin-based chemotherapy. J Clin Oncol 1998 1.04
29 Pulmonary evaluation of patients with osteosarcoma: roles of standard radiography, tomography, CT, scintigraphy, and tomoscintigraphy. AJR Am J Roentgenol 1984 1.01
30 Response of small-cell lung cancer xenografts to chemotherapy: multidrug resistance and direct clinical correlates. J Natl Cancer Inst 1993 1.00
31 Conservative management of breast cancer. Br J Surg 1986 1.00
32 Management of cancer in pregnancy: a case of Ewing's sarcoma of the pelvis in the third trimester. Ann Oncol 1999 0.97
33 Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung carcinoma. Cancer 1998 0.97
34 HOX gene expression in human small-cell lung cancers xenografted into nude mice. Int J Cancer 1994 0.95
35 High-dose-rate brachytherapy as sole modality for early-stage endobronchial carcinoma. Int J Radiat Oncol Biol Phys 2000 0.94
36 The cost-effectiveness of navelbine alone or in combination with cisplatin in comparison to other chemotherapy regimens and best supportive care in stage IV non-small cell lung cancer. Eur J Cancer 1996 0.94
37 Phase I-II and pharmacokinetic study of gemcitabine combined with oxaliplatin in patients with advanced non-small-cell lung cancer and ovarian carcinoma. Ann Oncol 2002 0.93
38 Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclasses. Ann Oncol 2012 0.92
39 Phase I study of PKC412 (N-benzoyl-staurosporine), a novel oral protein kinase C inhibitor, combined with gemcitabine and cisplatin in patients with non-small-cell lung cancer. Ann Oncol 2004 0.92
40 Recombinant adenovirus shedding after intratumoral gene transfer in lung cancer patients. Gene Ther 2003 0.88
41 Review of the pemetrexed and gemcitabine combination in patients with advanced-stage non-small cell lung cancer. Ann Oncol 2006 0.88
42 Alternating radiotherapy and chemotherapy schedules in small cell lung cancer, limited disease. Int J Radiat Oncol Biol Phys 1985 0.87
43 [N-Methyl-9 hydroxy-ellipticine (NSC 264-137) in the treatment of malignant metastases. Preliminary results (author's transl)]. Nouv Presse Med 1981 0.87
44 Cardiac metastases. Case report on an isolated cardiac metastasis of a myxoid liposarcoma. Cancer 1986 0.87
45 Initial management of primary mediastinal seminoma: radiotherapy or cisplatin-based chemotherapy? Eur J Cancer 1998 0.87
46 Molecular prognostic factors in resectable non-small cell lung cancer. Crit Rev Oncol Hematol 2005 0.86
47 Competing events determining relapse-free survival in limited small-cell lung carcinoma. The French Cancer Centers' Lung Group. J Clin Oncol 1992 0.86
48 Is cisplatin still the best platinum compound in non-small-cell lung cancer? Ann Oncol 2002 0.85
49 Phase I-II study of vinorelbine (Navelbine) plus cisplatin in advanced non-small cell lung cancer. Eur J Cancer 1992 0.85
50 Pilot study of neoadjuvant ifosfamide, cisplatin, and etoposide in locally advanced non-small cell lung cancer. Eur J Cancer 1990 0.84
51 Combination raltitrexed (Tomudex(R))-oxaliplatin: a step forward in the struggle against mesothelioma? The Institut Gustave Roussy experience with chemotherapy and chemo-immunotherapy in mesothelioma. Eur J Cancer 2000 0.84
52 Combined systemic chemoimmunotherapy in advanced diffuse malignant mesothelioma. Report of a phase I-II study of weekly cisplatin/interferon alfa-2a. J Clin Oncol 1996 0.84
53 Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non-small cell lung cancer. J Thorac Cardiovasc Surg 2001 0.83
54 Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study. J Clin Oncol 1997 0.83
55 Identification and measurement of calcitonin precursors in serum of patients with malignant diseases. Cancer Res 1989 0.83
56 Differential expression of biomarkers in lung adenocarcinoma: a comparative study between smokers and never-smokers. Ann Oncol 2005 0.83
57 Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected nonsmall cell lung carcinoma. A randomized trial of 267 patients. GETCB (Groupe d'Etude et de Traitement des Cancers Bronchiques). Cancer 1995 0.82
58 Dealing with initial chemotherapy doses: a new basis for treatment optimisation in limited small-cell lung cancer. Ann Oncol 1995 0.82
59 Pattern of failure in patients with inflammatory breast cancer treated by alternating radiotherapy and chemotherapy. Cancer 1995 0.82
60 Non-small cell lung cancer: an overview of current management. Eur J Cancer 1997 0.81
61 Chemotherapy and combined modality therapy for locally advanced and metastatic gastric carcinoma. Semin Oncol 1985 0.81
62 Combination of raltitrexed and oxaliplatin is an active regimen in malignant mesothelioma: results of a phase II study. J Clin Oncol 2003 0.81
63 Use of chemo-radiotherapy in locally advanced non-small cell lung cancer. Eur J Cancer 2002 0.81
64 Liver metastases from extremity soft tissue sarcoma. Am J Clin Oncol 1999 0.80
65 Ca125 and neuron-specific enolase (NSE) as tumour markers for intra-abdominal desmoplastic small round-cell tumours. Br J Cancer 1997 0.80
66 Should the number of pulmonary metastases influence the surgical decision? Eur J Cardiothorac Surg 1997 0.80
67 Phase II study of elliptinium in advanced breast cancer. Cancer Treat Rep 1985 0.80
68 A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignancies. Ann Oncol 2000 0.80
69 Prophylactic cranial irradiation for small-cell lung cancer. Lancet 1997 0.79
70 Radical radiotherapy alone in non-operable breast cancer: the major impact of tumor size and histological grade on prognosis. Radiother Oncol 1988 0.79
71 Pneumonectomy for lung metastases: indications, risks, and outcome. Ann Thorac Surg 1998 0.79
72 Surgery for pulmonary metastases. Who are the 10-year survivors? Cancer 1994 0.79
73 Chemotherapy of stage IIIB and IV non-small-cell lung cancer. Ann Oncol 1995 0.78
74 Phase II study of nitrosourea fotemustine as single-drug chemotherapy in poor-prognosis non-small-cell lung cancer. Br J Cancer 1994 0.78
75 Patterns of failure in a randomized trial of adjuvant chemotherapy in postmenopausal patients with early breast cancer treated with tamoxifen. Ann Oncol 2002 0.78
76 Phase II trial of methotrexate-FAM (m-FAM) in adenocarcinoma of unknown primary. Eur J Cancer Clin Oncol 1989 0.78
77 Adding a reverser (verapamil) to combined chemotherapy overrides resistance in small cell lung cancer xenografts. Eur J Cancer 1995 0.78
78 Re: Stage IIIA category of non-small-cell lung cancer: a new proposal. J Natl Cancer Inst 1997 0.78
79 Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non-small cell lung cancer. Cancer 1995 0.78
80 Combination interleukin-2 and doxorubicin in advanced adult solid tumors: circumvention of doxorubicin resistance in soft-tissue sarcoma? J Immunother 1999 0.78
81 [Soft tissue sarcomas: general review]. Bull Cancer 1994 0.78
82 Surgical resection of pulmonary metastases. Up to what number? Am J Respir Crit Care Med 1994 0.78
83 Response of a multidrug-resistant human small-cell lung cancer xenograft to chemotherapy. J Cancer Res Clin Oncol 1993 0.78
84 Her2-neu: a target in lung cancer? Ann Oncol 2004 0.77
85 Triangular test and randomized trials: practical problems in a small cell lung cancer trial. Stat Med 1994 0.77
86 A phase I trial with recombinant interferon gamma (Roussel UCLAF) in advanced cancer patients. Cancer Immunol Immunother 1990 0.77
87 [Modalities of radiotherapy in small cell lung cancer: thoracic radiotherapy and prophylactic cerebral irradiation]. Rev Pneumol Clin 2004 0.77
88 Phase II study of elliptinium acetate salvage treatment of advanced breast cancer. Eur J Cancer 1993 0.77
89 [Primary mediastinal non-seminomatous germ-cell tumors: from clinics to biology]. Bull Cancer 1997 0.77
90 Developments in the treatment of early NSCLC: when to use chemotherapy. Ann Oncol 2012 0.76
91 Alternating radiotherapy and chemotherapy schedules in limited small cell lung cancer: analysis of local chest recurrences. Radiother Oncol 1991 0.76
92 [Zd 1839 "Iressa"]. Bull Cancer 2000 0.76
93 [Angiosarcoma of the breast. Apropos of 8 cases and review of the literature]. Bull Cancer 1997 0.75
94 Phase II trial of raltitrexed ('Tomudex') in advanced small-cell lung cancer. Br J Cancer 1997 0.75
95 Front-line doublets in advanced non-small cell lung cancer: The golden age for second line chemotherapy. Ann Oncol 2005 0.75
96 Initial chemotherapeutic doses and long-term survival in limited small-cell lung cancer. N Engl J Med 2001 0.75
97 Chemotherapy for non-small-cell lung carcinoma, a look at the past decade. Ann Oncol 2000 0.75
98 Small cell lung cancer and prophylactic cranial irradiation (PCI): perhaps the question is not who needs PCI but who wants PCI? Eur J Cancer 1997 0.75
99 European perspectives on paclitaxel/platinum-based therapy for advanced non-small cell lung cancer. Semin Oncol 2001 0.75
100 Lung resection for recurrence after pneumonectomy for metastases. Bull Cancer 1997 0.75
101 [Current methods of diagnosis of primary hyperparathyroidism]. Acquis Med Recent 1978 0.75
102 Neoadjuvant chemotherapy of locally advanced non-small cell lung cancer. Lung Cancer 1995 0.75
103 Alternating radiotherapy and chemotherapy in limited small cell lung cancer: the IGR protocols. French FNCLCC Lung Cancer Study Group. Lung Cancer 1994 0.75
104 [Primary chemotherapy in soft tissue sarcomas considered inoperable]. Sem Hop 1983 0.75
105 [Bronchial endoscopy in the diagnostic and developmental evaluation of small cell broncho-pulmonary cancer]. Bull Cancer 1987 0.75
106 Expanding role of chemotherapy in lung cancer. Ann Oncol 2006 0.75
107 [High-doses chemotherapy followed by bone marrow autograft in the treatment of small cell bronchial cancer]. Bull Cancer 1987 0.75
108 Persistence of viable tumor cells after radiation and chemotherapy for stage IIIB non-small cell lung cancer: an early marker of treatment failure. J Thorac Cardiovasc Surg 2001 0.75
109 [Sequential chemotherapy and radiotherapy in inoperable squamous cell lung cancer (author's transl)]. Bull Cancer 1981 0.75
110 Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practice. Lung Cancer 2000 0.75
111 [Combination vindesine, cyclophosphamide, cis-platinum and CCNU in esophageal epidermoid cancer. Preliminary analysis of 64 cases]. Bull Cancer 1985 0.75
112 [New therapeutic strategies and current research in inoperable locally advanced non small-cell lung cancers (stage IIIB)]. Bull Cancer 1997 0.75
113 Long-term results of neoadjuvant ifosfamide, cisplatin, and etoposide combination in locally advanced non-small-cell lung cancer. Chest 1994 0.75
114 Hypothyroidism and goiter during interleukin-2 therapy. J Endocrinol Invest 1990 0.75
115 Combined chemotherapy and radiotherapy in small-cell lung cancer. Cancer Treat Res 1991 0.75
116 [Results of a phase II study of the combination of cis-platinum and 5-FU in epidermoid or undifferentiated large cell bronchial cancer]. Bull Cancer 1989 0.75
117 [Chemotherapy of soft tissue sarcoma in adults]. Bull Acad Natl Med 1991 0.75
118 [Inoperable lung epidermoid cancer non metastasizing. A phase II trial using radiotherapy and combined chemotherapy]. Bull Cancer 1985 0.75
119 Phase II study of a combination of elliptinium and vinblastine in metastatic breast cancer. Invest New Drugs 1992 0.75
120 [Adjuvant chemotherapy in the early stages of non-small cell bronchial cancers]. Rev Pneumol Clin 2002 0.75
121 Cisplatin-fotemustine combination in inoperable non-small cell lung cancer: preliminary report of a French multicentre phase II trial. Eur J Cancer 1994 0.75
122 Combined radiation and chemotherapy for unresectable non-small cell lung carcinoma. Lung Cancer 1994 0.75
123 Postoperative chemotherapy in non-small cell lung cancer. Tumori 2001 0.75
124 [Liver metastasis of breast cancers. Value of chemotherapy]. Nouv Presse Med 1980 0.75
125 [Mesenchymal breast sarcomas. Apropos of 25 cases]. Bull Cancer 1985 0.75
126 [2 N methyl 9 hydroxy-ellipticine in treatment of metastatic breast cancers (author's transl)]. Bull Cancer 1981 0.75
127 [Surgical treatment of pulmonary metastases in adult patients (author's transl)]. Nouv Presse Med 1982 0.75
128 [Recent progress in the biology of small cell bronchial carcinoma]. Rev Mal Respir 1988 0.75
129 [Sequential chemotherapy and radiotherapy modalities in small cell lung carcinoma. Preliminary results]. Bull Cancer 1982 0.75
130 [Phase I trial of a recombinant human interleukin 2. Results in patients with disseminated solid tumors]. Presse Med 1991 0.75
131 [Chemotherapy in small cell bronchial carcinoma]. Bull Cancer 1987 0.75
132 Invasive carcinoma of the thymus. A multicenter retrospective review of 56 cases. Eur J Cancer Clin Oncol 1984 0.75
133 Should chemotherapy response be evaluated separately in sequential chemotherapy-radiotherapy schedules in locally advanced nonsmall-cell lung carcinoma? Antibiot Chemother (1971) 1988 0.75
134 [Optimization of combined radiotherapy and chemotherapy in treatment of non-small cell lung carcinoma]. Cancer Radiother 1997 0.75
135 [Liposarcoma in adults. Prognostic factors in a series of 84 cases (author's transl)]. Nouv Presse Med 1981 0.75
136 Concurrent cisplatin-vindesine and hyperfractionated thoracic radiotherapy in locally advanced nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 1996 0.75
137 [Transient cerebral manifestations induced by intrathecal injection of methotrexate]. Nouv Presse Med 1979 0.75
138 [Combined radiotherapy-chemotherapy in inoperable bronchial carcinoma (small cell carcinoma excluded)]. Bull Cancer 1990 0.75
139 [Combination of chemotherapy (vindesine, lomustine, cisplatin, cyclophosphamide) and thoracic radiotherapy in nonresectable non-small cell bronchial carcinoma: final results of a phase II clinical trial]. Bull Cancer 1992 0.75
140 Phase II study of pirarubicin in advanced non-small cell lung cancer. Eur J Cancer Clin Oncol 1989 0.75
141 [Respiratory sequellae after alternated chemotherapy and radiotherapy for small cell anaplastic cancer]. Bull Cancer 1987 0.75
142 [Role of radiotherapy in the treatment of small cell lung carcinoma]. Rev Pneumol Clin 1989 0.75
143 Extensive small-cell lung cancer. A randomized comparison of two chemotherapy programs with early crossover in instances of failure. Association pour le Traitement des Tumeurs Intra-Thoraciques (ATTIT). Ann Oncol 1992 0.75
144 [Treatment of metastatic renal cancer in adults with elliptinium acetate]. Presse Med 1984 0.75
145 Prophylactic cranial irradiation in small cell lung cancer. Lancet 1985 0.75
146 [Meningeal carcinomatosis in adults (author's transl)]. Sem Hop 1982 0.75
147 [Initial chemotherapy in the treatment of inflammatory breast cancers. 230 cases]. Presse Med 1987 0.75
148 Impact of chemotherapy on survival in locally advanced non-small cell lung cancer: the Gustave-Roussy experience. Lung Cancer 1995 0.75
149 Combined chemotherapy (vindesine, lomustine, cisplatin, and cyclophosphamide) and radical radiotherapy in inoperable nonmetastatic squamous cell carcinoma of the lung. Cancer Treat Rep 1985 0.75
150 Alternating radiotherapy and chemotherapy in limited disease small cell lung cancer. Radiother Oncol 1998 0.75
151 First-line vinorelbine-mitoxantrone combination in metastatic breast cancer patients relapsing after an adjuvant anthracycline regimen: results of a phase II study. Oncology 1998 0.75
152 Endoscopic diagnosis of small anaplastic carcinoma: difficulties and means of determining contour. Bull Cancer 1982 0.75
153 The role of chest irradiation in small cell lung cancer. Cancer Treat Res 1995 0.75
154 Report of the IASLC Le Havre Workshop. Chest 1989 0.75
155 [Treatment of inflammatory cancer of the breast. Combined chemotherapy and radiotherapy. Apropos of 270 women treated at the Institut Gustave-Roussy]. Bull Cancer 1989 0.75
156 Effectiveness of interleukin-2 in invasive lymphoepithelial thymoma. Lancet 1990 0.75
157 [Superior vena cava compression syndrome. Apropos of 69 cases]. Sem Hop 1983 0.75
158 [Therapeutic advances in small cell bronchial cancers]. Presse Med 1988 0.75
159 Phase I-II and pharmacokinetic study of a new fotemustine schedule in advanced non-small cell lung cancer. Lung Cancer 1995 0.75
160 [Standards, Options and Recommendations for the management of stage I or II primary bronchial cancers treated exclusively with radiotherapy]. Cancer Radiother 2001 0.75
161 Prognostic value of initial chemotherapy doses in limited small cell lung cancer. Antibiot Chemother (1971) 1988 0.75
162 Epithelioid sarcoma of soft tissues: a case of extrarenal renin-secreting tumour. J Hum Hypertens 1988 0.75
163 Dose intensity in lung cancer treatment. Lung Cancer 1994 0.75
164 [Update on pulmonary cancerology. What is new in 1997]. Bull Cancer 1998 0.75
165 Dose optimisation and intensification of cytotoxics in solid tumours supported by haematopoietic growth factors. Eur J Cancer 1994 0.75
166 [Standards, options and recommendations for the management of locally advanced non small cell lung carcinoma]. Bull Cancer 2001 0.75
167 Phase II study of pirarubicin in advanced non-small cell lung cancer. Eur J Cancer Clin Oncol 1989 0.75
168 Eve of the third millennium, providing an update on the management of non-small cell lung cancer (NSCLC). Anticancer Drugs 2001 0.75
169 Management of unresectable non-small cell carcinoma of the lung (NSCLC). Lung Cancer 2003 0.75
170 [Inappropriate antidiuretic hormone secretion disclosing a second primary lung cancer 5 years after complete remission of a small cell lung carcinoma]. Bull Cancer 1996 0.75
171 [Phase I trial of recombinant human granulocyte-macrophage colony stimulating factor. Results in patients with advanced tumors]. Bull Cancer 1993 0.75
172 [Manifestations of cerebral metastases: diagnostic and therapeutic importance of research on their primary sites in 120 cases]. Bull Cancer 1982 0.75
173 [Metastases from cancers of unknown primary site. Data from 302 autopsies]. Presse Med 1991 0.75
174 Consensus report on combined radiotherapy and chemotherapy modalities in lung cancer. Antibiot Chemother (1971) 1988 0.75
175 [Epidemiology, prognostic factors, staging, and treatment of non-small cell lung cancer]. Bull Cancer 1999 0.75
176 Ongoing/planned studies in France Stage I-II NSCLC. Lung Cancer 2001 0.75
177 [Alternating chemotherapy and radiotherapy in the induction treatment of small cell bronchial carcinoma (forms limited to the thorax)]. Presse Med 1985 0.75
178 Limited small cell lung cancer: possible prognostic impact of initial chemotherapy doses. Bull Cancer 1989 0.75
179 [Prophylactic brain irradiation in small cell bronchial carcinomas]. Bull Cancer 1987 0.75
180 Serum neuron-specific enolase (NSE) as a tumour marker for the Ewing's sarcoma family of tumours. Eur J Cancer 1996 0.75
181 Establishment and characterization of five human small cell lung cancer cell lines from early tumor xenografts. Anticancer Res 1995 0.75
182 [Non-small cell bronchial cancer with mediastinal invasion]. Bull Cancer 1999 0.75